Barrier Failure in Psoriasis Reflects Calcium Dysfunction

Psoriasis plaques persist when the epidermal calcium gradient and intracellular calcium regulation are disrupted, leading to continued keratinocyte proliferation with incomplete terminal differentiation and impaired barrier restoration.

Executive Summary

Psoriasis plaques persist when keratinocytes fail to transition from hyperproliferation to stable terminal differentiation, so barrier competence never fully returns. The mechanistic bottleneck is mistimed intracellular ionic calcium handling that disrupts ER calcium refilling and mitochondrial calcium support, leaving cornified envelope assembly, lipid processing, and adhesion out of sync. That barrier instability sustains a water-loss and microtrauma cycle that keeps inflammatory activation “on,” so restoring coherent calcium signaling upstream targets the conditions that allow plaques to persist.

Plaque Persistence and Calcium Signaling Dysregulation

Psoriasis is expressed on the skin surface, but plaque maintenance reflects signaling disturbance within the epidermis. Calcium handling connects the clinical phenotype to the underlying epidermal differentiation and barrier process. Scaling, erythema, itch, fissuring. These features are associated with disordered transitions from keratinocyte proliferation to terminal differentiation, and with a barrier that does not fully normalize.In healthy epidermis, calcium distribution differs by layer. It is relatively low in basal keratinocytes, rises toward the granular layer, then falls again in the uppermost layer. That rise functions as a differentiation cue and coordinates terminal steps such as cornified envelope formation and barrier lipid processing. In psoriasis, the pattern becomes flattened, displaced, or internally inconsistent. Basal and lower suprabasal compartments remain in a relatively low extracellular calcium environment that favors continued cycling, while suprabasal layers show abnormal calcium signaling and lose the normal stepwise differentiation sequence. Histology aligns with this physiology: parakeratosis, retained nuclei, and impaired barrier integrity. Clinically, barrier impairment increases sensitivity to friction and detergents, sustains recurrent irritation, and increases the risk of secondary infection in susceptible patients.

This is not explained by passive diffusion alone. It reflects active calcium storage and calcium entry coupled to endoplasmic reticulum function, including store-operated calcium entry. Store-operated calcium entry is the replenishment mechanism that restores cytosolic calcium after endoplasmic reticulum calcium release, coordinated by stromal interaction molecule 1 (STIM1) sensors and Orai1 calcium release-activated calcium modulator 1 channels. When this axis is unstable, calcium-dependent transcription timing shifts, adhesion programs weaken, and lipid processing and envelope assembly become misaligned with proliferation. Immune activation then becomes easier to sustain within the plaque because dendritic cells and T cells use calcium flux to set activation thresholds, reinforcing the interleukin-23-to-T helper 17-to-interleukin-17 circuit and maintaining high keratinocyte inflammatory output. Mahonia aquifolium extract contains berberine and can inhibit keratinocyte proliferation by suppressing nuclear factor kappa B and signal transducer and activator of transcription 3. It can also reduce mediators such as interleukin-8 and leukotriene B4, consistent with reduced vasodilation and reduced neutrophil-driven plaque activity. Aloe vera gel contains acemannan and can support keratinocyte differentiation through stronger transforming growth factor beta signaling. It can also reduce surface oxidative stress and help preserve barrier lipids, consistent with reduced itch and reduced barrier fragility.

AIC Therapy is presented as disease-relevant in psoriasis because it targets calcium signaling at a regulatory level that influences whether keratinocytes remain proliferative or enter terminal differentiation. When calcium timing becomes more coherent and the epidermal calcium gradient stabilizes, parakeratosis and barrier impairment can be resolved by targeting the initiating biology rather than addressing only downstream inflammatory endpoints. As barrier integrity improves, keratinocyte stress signaling decreases, local triggers for dendritic cell and T cell activation weaken, and sustained immune activation within the plaque declines.

This figure demonstrates: (A) The feedback loops that couple the epidermal barrier to transepidermal water loss (TEWL), water flow, and calcium flow. Humidity (H) inversely affects TEWL. TEWL drives water movement and, through that, influences calcium movement (solid arrows). When the barrier is absent, water and calcium levels drop, which triggers non-homeostatic differentiation and barrier formation (dashed arrows). Once the barrier forms, it locally slows TEWL and reduces water and calcium flow, allowing calcium to accumulate in the SS and support homeostatic differentiation. Differentiated cells in the SG and SC then maintain the barrier, and negative feedback between calcium flow and barrier strength stabilizes tissue thickness. (B) The schematic shows the spatial organization under homeostatic conditions. Basal cells have access to water and calcium. Surface cells lose water through TEWL, which drives apical water diffusion and a coupled, directed calcium transport, opposed by calcium diffusion. The barrier reduces local water and calcium flow. It is formed by stacks of flattened SG and SC cells containing tight junctions (SG and SC) and lipids (SC), leading to calcium accumulation in the underlying layers. (C) The schematic shows how the control loops change as the model epidermis grows from a few stem cells (I) to a stable tissue (IV). Early on, there is no barrier, so water and calcium flow are uncontrolled (I). This activates non-homeostatic rescue loops (dashed arrows) that build a transient ectopic barrier (II and III). That transient barrier protects deeper layers, allowing normal differentiation and homeostasis (IV).

Sütterlin, T., Tsingos, E., Bensaci, J. et al. A 3D self-organizing multicellular epidermis model of barrier formation and hydration with realistic cell morphology based on EPISIM. Sci Rep 7 , 43472 (2017). https://doi.org/10.1038/srep43472

This Figure demonstrates that SerpinB7 deficiency disrupts the skin barrier and exacerbates IMQ-induced psoriatic inflammation. The figure also shows that SerpinB7 deficiency inhibits keratinocyte differentiation and promotes the expression of inflammatory cytokines and antimicrobial peptides by attenuating intracellular calcium concentration ([Ca2+]c) and mitochondrial calcium concentration ([Ca2+]m). Together, these data identify SerpinB7 as a keratinocyte-specific molecule involved in psoriasis pathogenesis and illustrate a mechanism in which SerpinB7 influences [Ca2+]c and [Ca2+]m to regulate keratinocyte differentiation and the inflammatory response.

Zheng, H., Gu, L., Zhao, F. et al. SerpinB7 deficiency contributes to development of psoriasis via calcium-mediated keratinocyte differentiation dysfunction. Cell Death Dis 13 , 635 (2022). https://doi.org/10.1038/s41419-022-05045-8

Mechanism-to-Clinic Trigger

If a plaque remains thick but fissures persist, prioritize impaired barrier maturation rather than residual inflammation as the primary explanation. If pruritus improves while fissuring continues, consider incomplete terminal differentiation. With frequent friction, detergents, and repeated washing, epidermal turnover increases, delaying barrier recovery. On histology, parakeratosis and retained nuclei indicate that terminal differentiation has not completed. In this context, calcium handling is usually abnormal because the epidermal calcium gradient regulates the transition from keratinocyte proliferation to maturation. Clinically, the key distinction is whether management is limited to reducing cytokine activity or also corrects calcium-dependent differentiation and barrier structure that supports plaque persistence.

Case Reference

A 25-year-old female was diagnosed with psoriasis. She started AIC Therapy and reported symptom improvement over six months. During the first week, she experienced a short-lived healing reaction, after which her symptoms began to improve. After a marked clinical response, she transitioned to a maintenance dose. The residual scars faded gradually and took more than a year to disappear.

Conclusion

Psoriasis is visible on the skin surface, but plaque persistence reflects disordered epidermal signaling, with scaling, erythema, pruritus, and fissuring tracking incomplete barrier normalization. In healthy epidermis, calcium is relatively low in basal keratinocytes, rises toward the granular layer, then falls again at the surface, and the granular rise coordinates terminal differentiation, cornified envelope formation, and barrier lipid processing. In psoriasis, this layer pattern becomes flattened or displaced, basal and lower suprabasal compartments remain in a low-calcium milieu that favors continued cycling, and suprabasal layers lose the stepwise differentiation sequence, consistent with parakeratosis, retained nuclei, and impaired barrier integrity. This is not passive diffusion; it reflects active intracellular calcium storage and calcium entry coupled to endoplasmic reticulum function, so calcium-dependent transcription timing shifts, adhesion programs weaken, and lipid processing and envelope assembly become misaligned with proliferation. Barrier failure increases transepidermal water loss and sensitivity to friction, detergents, and frequent washing, creating a hydration-bariyer loop in which water movement and calcium distribution destabilize each other and sustain a high-turnover epidermis. Mechanistic data also link impaired keratinocyte differentiation to reduced intracellular and mitochondrial calcium signals, with increased levels of inflammatory cytokines and antimicrobial peptides when barrier-specific regulators, such as SerpinB7, are deficient. Taken together, plaque persistence is best explained as a calcium-driven failure of barrier completion, and AIC Therapy treats psoriasis by stabilizing calcium signaling that commits keratinocytes to terminal differentiation and restores the epidermal gradient that supports barrier closure. In the provided case, a 25-year-old female improved over six months on AIC Therapy, transitioned to maintenance dosing after a marked response, and showed gradual scar fading over more than a year, consistent with sustained barrier restoration and reduced local immune activation within plaques.

Newsletter content is educational and contributed by participating healthcare practitioners. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.